Expression of CD28, CTLA4, CD80, and CD86 Molecules in Patients with Autoimmune Rheumatic Diseases: Implications for Immunotherapy

By Sfikakis P.P.   Via C.S.  

Clinical Immunology, Vol. 83, Iss. 3, 1997-06 ,pp. : 195-198

Academic Press

Access to resources Recommend Favorite

Islet-Infiltrating T Lymphocytes in Insulin-dependent Diabetic Patients Express CD80 (B7-1) and CD86 (B7-2)

By Imagawa A.   Hanafusa T.   Itoh N.   Miyagawa J.I.   Nakajima H.   Namba M.   Kuwajima M.   Tamura S.   Kawata S.   Matsuzawa Y.   Harlan D.M.  

Journal of Autoimmunity, Vol. 9, Iss. 3, 1996-03 ,pp. : 391-396

Academic Press

Access to resources Recommend Favorite

Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas - reactivity toward the malignant clone

By Chaperot L.   Plumas J.   Jacob M.-C.   Bost F.   Molens J.-P.   Sotto J.-J.   Bensa J.-C.  

Experimental Hematology, Vol. 27, Iss. 3, 1999-03 ,pp. : 479-488

Elsevier

Access to resources Recommend Favorite

What's the difference between CD80 and CD86?

By Sansom D.M.   Manzotti C.N.   Zheng Y.  

Trends in Immunology, Vol. 24, Iss. 6, 2003-06 ,pp. : 313-318

Elsevier

Access to resources Recommend Favorite

Expression of Inhibitory Receptors in Natural Killer (CD3^-CD56⁺) Cells and CD3⁺CD56⁺ Cells in the Peripheral Blood Lymphocytes and Tumor Infiltrating Lymphocytes in Patients with Primary Hepatocellular Carcinoma

By Yuen M-F.   Norris S.  

Clinical Immunology, Vol. 101, Iss. 3, 2001-12 ,pp. : 264-269

Academic Press

Access to resources Recommend Favorite